Zobrazeno 1 - 10 of 21 pro vyhledávání: '"B. Kloesch"'
5
Inhibitors of p38 and ERK1/2 MAPkinase and hydrogen sulphide block constitutive and IL-1β-induced IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2
Autor: B. Kloesch, J. Bröll, M. Liszt, G. Steiner
Publikováno v: Rheumatology International. 32:729-736
Mitogen-activated protein kinases (MAPKs) play a central role in inflammatory processes, and their blockage represents pharmacological approaches in the treatment of autoimmune diseases like rheumatoid arthritis (RA). Alternatively, H(2)S has long be
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b673626bee0d013b9166124ca5ef1de3
https://doi.org/10.1007/s00296-010-1682-0
Zobrazit plný text záznamu
7
Akademický článek
Polysulfides derived from the hydrogen sulfide and persulfide donor P* inhibit IL-1β-mediated inducible nitric oxide synthase signaling in ATDC5 cells: are CCAAT/enhancer-binding proteins β and δ involved in the anti-inflammatory effects of hydrogen sulfide and polysulfides?
Autor: Trummer M; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, 1090, Vienna, Austria; Department of Pharmacology and Toxicology, Institute of Pharmaceutical Sciences, University of Graz, 8010, Graz, Austria., Galardon E; UMR 8601, LCBPT, CNRS-Université de Paris, 75270, Paris, France., Mayer B; Department of Pharmacology and Toxicology, Institute of Pharmaceutical Sciences, University of Graz, 8010, Graz, Austria., Steiner G; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, 1090, Vienna, Austria; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, 1090, Vienna, Austria., Stamm T; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, 1090, Vienna, Austria; Section for Outcomes Research, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, 1090, Vienna, Austria., Kloesch B; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, 1090, Vienna, Austria; Department of Pharmacology and Toxicology, Institute of Pharmaceutical Sciences, University of Graz, 8010, Graz, Austria. Electronic address: burkhard.kloesch@uni-graz.at.
Publikováno v: Nitric oxide : biology and chemistry [Nitric Oxide] 2022 Dec 01; Vol. 129, pp. 41-52. Date of Electronic Publication: 2022 Oct 08.
Zobrazit plný text záznamu
8
Akademický článek
A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer.
Autor: Kloesch B; Institute of Cancer Research, Departmet of Medicine I, Medical University of Vienna, Wien, Austria.; Comprehensive Cancer Center, Medical University Vienna, Wien, Austria., Ionasz V; Institute of Cancer Research, Departmet of Medicine I, Medical University of Vienna, Wien, Austria.; Comprehensive Cancer Center, Medical University Vienna, Wien, Austria., Paliwal S; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO), CIBERONC, Madrid, Spain., Hruschka N; Institute of Cancer Research, Departmet of Medicine I, Medical University of Vienna, Wien, Austria.; Comprehensive Cancer Center, Medical University Vienna, Wien, Austria., Martinez de Villarreal J; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO), CIBERONC, Madrid, Spain., Öllinger R; Center for Translational Cancer Research, Technical University Munich, Munich, Germany.; Institute of Molecular Oncology and Functional Genomics, Technical University Munich, Munich, Germany., Mueller S; Center for Translational Cancer Research, Technical University Munich, Munich, Germany.; Institute of Molecular Oncology and Functional Genomics, Technical University Munich, Munich, Germany., Dienes HP; Department of Pathology, Medical University of Vienna, Vienna, Austria., Schindl M; Comprehensive Cancer Center, Medical University Vienna, Wien, Austria.; Division of General Surgery, Medical University of Vienna, Wien, Austria., Gruber ES; Comprehensive Cancer Center, Medical University Vienna, Wien, Austria.; Division of General Surgery, Medical University of Vienna, Wien, Austria., Stift J; Department of Pathology, Medical University of Vienna, Vienna, Austria., Herndler-Brandstetter D; Institute of Cancer Research, Departmet of Medicine I, Medical University of Vienna, Wien, Austria.; Comprehensive Cancer Center, Medical University Vienna, Wien, Austria., Lomberk GA; Genomics Sciences and Precision Medicine Center and Division of Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Seidler B; Center for Translational Cancer Research, Technical University Munich, Munich, Germany.; Department of Medicine II, Klinikum rechts der Isar, Technical University Munich, Munich, Gemany., Saur D; Center for Translational Cancer Research, Technical University Munich, Munich, Germany.; Department of Medicine II, Klinikum rechts der Isar, Technical University Munich, Munich, Gemany.; German Cancer Consortium (DKTK), German Cancer Research Consortium (DKFZ), Heidelberg, Germany., Rad R; Center for Translational Cancer Research, Technical University Munich, Munich, Germany.; Department of Medicine II, Klinikum rechts der Isar, Technical University Munich, Munich, Gemany.; German Cancer Consortium (DKTK), German Cancer Research Consortium (DKFZ), Heidelberg, Germany., Urrutia RA; Genomics Sciences and Precision Medicine Center and Division of Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Real FX; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO), CIBERONC, Madrid, Spain.; Departament de Ciènces Experimental i de la Salut, Pompeu Fabra University, Barcelona, Spain., Martinelli P; Institute of Cancer Research, Departmet of Medicine I, Medical University of Vienna, Wien, Austria paola.martinelli@boehringer-ingelheim.com.; Comprehensive Cancer Center, Medical University Vienna, Wien, Austria.
Publikováno v: Gut [Gut] 2022 Apr; Vol. 71 (4), pp. 766-777. Date of Electronic Publication: 2021 Apr 12.
Zobrazit plný text záznamu
9
Akademický článek
Characterization of the Inducible and Slow-Releasing Hydrogen Sulfide and Persulfide Donor P*: Insights into Hydrogen Sulfide Signaling.
Autor: Trummer M; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, 1090 Vienna, Austria.; Department of Pharmacology and Toxicology, Institute of Pharmaceutical Sciences, Karl-Franzens-University of Graz, 8010 Graz, Austria., Galardon E; UMR 8601, LCBPT, CNRS-Université de Paris, 75270 Paris, France., Fischer A; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, 1090 Vienna, Austria.; Karl Chiari Lab for Orthopaedic Biology, Department of Orthopedics and Trauma Surgery, Medical University of Vienna, 1090 Vienna, Austria., Toegel S; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, 1090 Vienna, Austria.; Karl Chiari Lab for Orthopaedic Biology, Department of Orthopedics and Trauma Surgery, Medical University of Vienna, 1090 Vienna, Austria., Mayer B; Department of Pharmacology and Toxicology, Institute of Pharmaceutical Sciences, Karl-Franzens-University of Graz, 8010 Graz, Austria., Steiner G; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, 1090 Vienna, Austria.; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria., Kloesch B; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, 1090 Vienna, Austria.; Department of Pharmacology and Toxicology, Institute of Pharmaceutical Sciences, Karl-Franzens-University of Graz, 8010 Graz, Austria.
Publikováno v: Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2021 Jun 29; Vol. 10 (7). Date of Electronic Publication: 2021 Jun 29.
Zobrazit plný text záznamu
10
Akademický článek
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver.
Autor: Hruschka N; Institute of Cancer Research, Medical University Vienna, Comprehensive Cancer Center, Vienna, Austria., Kalisz M; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre-CNIO, CIBERONC, Madrid, Spain., Subijana M; Institute of Cancer Research, Medical University Vienna, Comprehensive Cancer Center, Vienna, Austria., Graña-Castro O; Bioinformatics Unit, Spanish National Cancer Research Centre-CNIO, Madrid, Spain., Del Cano-Ochoa F; Department of Genome Dynamics and Function, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain., Brunet LP; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain., Chernukhin I; Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK., Sagrera A; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre-CNIO, CIBERONC, Madrid, Spain., De Reynies A; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, 75013, Paris, France., Kloesch B; Institute of Cancer Research, Medical University Vienna, Comprehensive Cancer Center, Vienna, Austria., Chin SF; Department of Oncology, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Burgués O; INCLIVA Biomedical Research Institute, Valencia, Spain.; Pathology Department, Hospital Clínico Universitario-CIBERONC, Valencia, Spain., Andreu D; Laboratory of Proteomics and Protein Chemistry, Universitat Pompeu Fabra, Barcelona, Spain., Bermejo B; INCLIVA Biomedical Research Institute, Valencia, Spain.; Oncology and Hematology Department, Hospital Clínico Universitario-CIBERONC, Valencia, Spain., Cejalvo JM; INCLIVA Biomedical Research Institute, Valencia, Spain.; Oncology and Hematology Department, Hospital Clínico Universitario-CIBERONC, Valencia, Spain., Sutton J; Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK., Caldas C; Department of Oncology, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Ramón-Maiques S; Department of Genome Dynamics and Function, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain., Carroll JS; Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK., Prat A; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain., Real FX; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre-CNIO, CIBERONC, Madrid, Spain.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain., Martinelli P; Institute of Cancer Research, Medical University Vienna, Comprehensive Cancer Center, Vienna, Austria. paola.martinelli@boehringer-ingelheim.com.; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre-CNIO, CIBERONC, Madrid, Spain. paola.martinelli@boehringer-ingelheim.com.; Cancer Cell Signaling Department, Boehringer-Ingelheim RCV, Vienna, Austria. paola.martinelli@boehringer-ingelheim.com.
Publikováno v: Oncogene [Oncogene] 2020 Aug; Vol. 39 (32), pp. 5455-5467. Date of Electronic Publication: 2020 Jun 25.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje